研報掘金丨華鑫證券:維持金龍魚“買入”評級,業績有望進一步恢復
華鑫證券研報指出,金龍魚(300999.SZ)2024年歸母淨利潤25.02 億元(同減12%),扣非淨利潤9.72 億元(同減26%),主要受公司折舊、產能爬坡進度影響。經營邊際改善,毛利率持續優化。公司作為廚房食品龍頭,短期受原材料成本波動影響收入承壓,但產品銷量仍穩步提升,並憑藉供應鏈優勢開拓央廚新藍海,看好公司渠道下沉帶來規模成長空間,目前市場需求 回暖,原材料及終端產品價格企穩回升,業績有望進一步恢復。根據年報, 預計2025-2027 年EPS 為0.52/0.65/0.84元,維持“買入”投資評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.